Craig-Hallum lowered the firm’s price target on Omnicell (OMCL) to $53 from $64 and keeps a Buy rating on the shares. The firm notes the company reported a strong Q1, with revenues growing 10%, a six-cent beat on adjusted EPS, and management noting increased interest in all their offerings. However, as expected, due to the turmoil surrounding tariffs, Omnicell guided down adjusted EBITDA and adjusted EPS, as tariffs are expected to reduce product gross margins by about 5%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell price target lowered to $30 from $37 at BofA
- Omnicell price target lowered to $40 from $62 at Benchmark
- Omnicell’s Resilience and Growth Potential: A Justified Buy Rating by Bill Sutherland
- Hold Rating for Omnicell Amid Tariff Challenges and Competitive Pressures
- Omnicell Reports Strong Q1 2025 Financial Results